Form 4: Mercedes Johnson Sells Teradyne Stock
Statement of Changes in Beneficial Ownership
Mercedes Johnson, a Director at Teradyne, Inc., reported a sale of common stock under a Rule 10b5-1 trading plan.
Summary
- Mercedes Johnson, a Director at Teradyne, Inc. (TER), has reported a transaction involving the sale of common stock.
- The sale occurred on July 1, 2026, and involved 167 shares sold at a price of $460 per share.
- Following this transaction, Johnson directly owns 6,697 shares.
- Additionally, 1,876 shares are held indirectly by The Mercedes Johnson Trust, where Johnson is the trustee and sole beneficiary.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the transaction was conducted under a pre-established Rule 10b5-1 plan, which is a common and accepted practice for insiders.
Negatives
- A Director of the company has sold a portion of their holdings.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings, like this one from Teradyne, are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan indicates a pre-arranged trading strategy, often employed to avoid concerns about insider trading.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The sale was made pursuant to a sales plan adopted by the Reporting Person on March 4, 2026, intended to comply with Rule 10b5-1. | 03/04/2026 | Standard practice for insider stock sales, designed to provide an affirmative defense against insider trading allegations. |
Stakeholder Impact
- Shareholders: The sale by a director may be perceived negatively, although the use of a 10b5-1 plan mitigates concerns about insider trading. The direct ownership of 6,697 shares and indirect ownership of 1,876 shares indicates continued significant holding.
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | Transaction Date for stock sale |
| 07/02/2026 | Date of Report Signature |
| 07/01/2026 | Earliest Transaction Date |
Keywords
Teradyne, TER, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.